Predominance of weakly cytotoxic, T-bet Low Eomes Neg CD8 + T-cells in human gastrointestinal mucosa: Implications for HIV infection

B. E. Kiniry, A. Ganesh, J. W. Critchfield, P. W. Hunt, F. M. Hecht, M. Somsouk, S. G. Deeks, Barbara Shacklett

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The gastrointestinal mucosa is an important site of HIV acquisition, viral replication, and pathogenesis. Immune cells in mucosal tissues frequently differ in phenotype and function from their non-mucosal counterparts. Although perforin-mediated cytotoxicity as measured in blood is a recognized correlate of HIV immune control, its role in gastrointestinal tissues is unknown. We sought to elucidate the cytotoxic features of rectal mucosal CD8 + T-cells in HIV infected and uninfected subjects. Perforin expression and lytic capacity were significantly reduced in rectal CD8 + T-cells compared with their blood counterparts, regardless of HIV clinical status; granzyme B (GrzB) was reduced to a lesser extent. Mucosal perforin and GrzB expression were higher in participants not on antiretroviral therapy compared with those on therapy and controls. Reduction in perforin and GrzB was not explained by differences in memory/effector subsets. Expression of T-bet and Eomesodermin was significantly lower in gut CD8 + T-cells compared with blood, and in vitro neutralization of TGF-β partially restored perforin expression in gut CD8 + T-cells. These findings suggest that rectal CD8 + T-cells are primarily non-cytotoxic, and phenotypically shaped by the tissue microenvironment. Further elucidation of rectal immune responses to HIV will inform the development of vaccines and immunotherapies targeted to mucosal tissues.

Original languageEnglish (US)
Pages (from-to)1008-1020
Number of pages13
JournalMucosal Immunology
Volume10
Issue number4
DOIs
StatePublished - Jul 1 2017

Fingerprint

HIV Infections
Mucous Membrane
Perforin
HIV
T-Lymphocytes
Granzymes
Immunotherapy
Vaccines
Phenotype
Therapeutics
perforin-granzyme B

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Predominance of weakly cytotoxic, T-bet Low Eomes Neg CD8 + T-cells in human gastrointestinal mucosa : Implications for HIV infection. / Kiniry, B. E.; Ganesh, A.; Critchfield, J. W.; Hunt, P. W.; Hecht, F. M.; Somsouk, M.; Deeks, S. G.; Shacklett, Barbara.

In: Mucosal Immunology, Vol. 10, No. 4, 01.07.2017, p. 1008-1020.

Research output: Contribution to journalArticle

Kiniry, B. E. ; Ganesh, A. ; Critchfield, J. W. ; Hunt, P. W. ; Hecht, F. M. ; Somsouk, M. ; Deeks, S. G. ; Shacklett, Barbara. / Predominance of weakly cytotoxic, T-bet Low Eomes Neg CD8 + T-cells in human gastrointestinal mucosa : Implications for HIV infection. In: Mucosal Immunology. 2017 ; Vol. 10, No. 4. pp. 1008-1020.
@article{b1ed578cefd84356b29848b02f18b7bc,
title = "Predominance of weakly cytotoxic, T-bet Low Eomes Neg CD8 + T-cells in human gastrointestinal mucosa: Implications for HIV infection",
abstract = "The gastrointestinal mucosa is an important site of HIV acquisition, viral replication, and pathogenesis. Immune cells in mucosal tissues frequently differ in phenotype and function from their non-mucosal counterparts. Although perforin-mediated cytotoxicity as measured in blood is a recognized correlate of HIV immune control, its role in gastrointestinal tissues is unknown. We sought to elucidate the cytotoxic features of rectal mucosal CD8 + T-cells in HIV infected and uninfected subjects. Perforin expression and lytic capacity were significantly reduced in rectal CD8 + T-cells compared with their blood counterparts, regardless of HIV clinical status; granzyme B (GrzB) was reduced to a lesser extent. Mucosal perforin and GrzB expression were higher in participants not on antiretroviral therapy compared with those on therapy and controls. Reduction in perforin and GrzB was not explained by differences in memory/effector subsets. Expression of T-bet and Eomesodermin was significantly lower in gut CD8 + T-cells compared with blood, and in vitro neutralization of TGF-β partially restored perforin expression in gut CD8 + T-cells. These findings suggest that rectal CD8 + T-cells are primarily non-cytotoxic, and phenotypically shaped by the tissue microenvironment. Further elucidation of rectal immune responses to HIV will inform the development of vaccines and immunotherapies targeted to mucosal tissues.",
author = "Kiniry, {B. E.} and A. Ganesh and Critchfield, {J. W.} and Hunt, {P. W.} and Hecht, {F. M.} and M. Somsouk and Deeks, {S. G.} and Barbara Shacklett",
year = "2017",
month = "7",
day = "1",
doi = "10.1038/mi.2016.100",
language = "English (US)",
volume = "10",
pages = "1008--1020",
journal = "Mucosal Immunology",
issn = "1933-0219",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Predominance of weakly cytotoxic, T-bet Low Eomes Neg CD8 + T-cells in human gastrointestinal mucosa

T2 - Implications for HIV infection

AU - Kiniry, B. E.

AU - Ganesh, A.

AU - Critchfield, J. W.

AU - Hunt, P. W.

AU - Hecht, F. M.

AU - Somsouk, M.

AU - Deeks, S. G.

AU - Shacklett, Barbara

PY - 2017/7/1

Y1 - 2017/7/1

N2 - The gastrointestinal mucosa is an important site of HIV acquisition, viral replication, and pathogenesis. Immune cells in mucosal tissues frequently differ in phenotype and function from their non-mucosal counterparts. Although perforin-mediated cytotoxicity as measured in blood is a recognized correlate of HIV immune control, its role in gastrointestinal tissues is unknown. We sought to elucidate the cytotoxic features of rectal mucosal CD8 + T-cells in HIV infected and uninfected subjects. Perforin expression and lytic capacity were significantly reduced in rectal CD8 + T-cells compared with their blood counterparts, regardless of HIV clinical status; granzyme B (GrzB) was reduced to a lesser extent. Mucosal perforin and GrzB expression were higher in participants not on antiretroviral therapy compared with those on therapy and controls. Reduction in perforin and GrzB was not explained by differences in memory/effector subsets. Expression of T-bet and Eomesodermin was significantly lower in gut CD8 + T-cells compared with blood, and in vitro neutralization of TGF-β partially restored perforin expression in gut CD8 + T-cells. These findings suggest that rectal CD8 + T-cells are primarily non-cytotoxic, and phenotypically shaped by the tissue microenvironment. Further elucidation of rectal immune responses to HIV will inform the development of vaccines and immunotherapies targeted to mucosal tissues.

AB - The gastrointestinal mucosa is an important site of HIV acquisition, viral replication, and pathogenesis. Immune cells in mucosal tissues frequently differ in phenotype and function from their non-mucosal counterparts. Although perforin-mediated cytotoxicity as measured in blood is a recognized correlate of HIV immune control, its role in gastrointestinal tissues is unknown. We sought to elucidate the cytotoxic features of rectal mucosal CD8 + T-cells in HIV infected and uninfected subjects. Perforin expression and lytic capacity were significantly reduced in rectal CD8 + T-cells compared with their blood counterparts, regardless of HIV clinical status; granzyme B (GrzB) was reduced to a lesser extent. Mucosal perforin and GrzB expression were higher in participants not on antiretroviral therapy compared with those on therapy and controls. Reduction in perforin and GrzB was not explained by differences in memory/effector subsets. Expression of T-bet and Eomesodermin was significantly lower in gut CD8 + T-cells compared with blood, and in vitro neutralization of TGF-β partially restored perforin expression in gut CD8 + T-cells. These findings suggest that rectal CD8 + T-cells are primarily non-cytotoxic, and phenotypically shaped by the tissue microenvironment. Further elucidation of rectal immune responses to HIV will inform the development of vaccines and immunotherapies targeted to mucosal tissues.

UR - http://www.scopus.com/inward/record.url?scp=85020906776&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020906776&partnerID=8YFLogxK

U2 - 10.1038/mi.2016.100

DO - 10.1038/mi.2016.100

M3 - Article

C2 - 27827375

AN - SCOPUS:85020906776

VL - 10

SP - 1008

EP - 1020

JO - Mucosal Immunology

JF - Mucosal Immunology

SN - 1933-0219

IS - 4

ER -